• Home
• Services
• One-Stop Microfluidic Solutions
• Organ-On-A-Chip Solution
• CBLMF™ 3D Tissue and Organ-On-A-Chip Model Development Services
• Prostate-Organ-On-A-Chip Model

Creative Biolabs' Prostate-On-A-Chip Model Development Service provides you with customized microfluidic platforms that mimic the intricate tumor microenvironment of prostate cancer. This enables more accurate and predictive in vitro studies of prostate cancer progression, metastasis, and drug responses. Our service delivers tailored solutions to address your specific research needs, from initial design to functional assay development.

Contact our team to get an inquiry now!

Background

Prostate cancer represents the second leading oncological diagnosis in U.S. men, exceeded only by cutaneous malignancies in occurrence and surpassed solely by pulmonary cancers in mortality. Epidemiological data estimate 288,300 new cases and 34,700 disease-related deaths anticipated in 2023. Clinically, a significant subset of prostate neoplasms demonstrates non-aggressive growth patterns rather than rapid dissemination. Physiological cellular specialization mechanisms generally preserve tissue equilibrium, though aberrant mitotic activity emerges during reparative processes or malignant transformation. Oncological initiation shows robust associations with prostate tumor-initiating cells (PCSCs), which mediate treatment resistance pathways and clinical relapse. Metastatic dissemination—characterized by hematogenous or lymphatic spread to skeletal, pulmonary, or hepatic systems—underlies most mortality through complications arising from secondary malignancies.

Fig 1. A comparison between normal and cancerous prostate.^1,4

Prostate cancer investigation, fundamental to biomedical discovery, depends on experimental platforms that simulate human physiology. Methodological selection critically determines experimental parameters, dictating resource allocation, temporal investment, and data interpretability. Conventionally, 2D cellular models and whole-organism studies have dominated biological inquiry—each presenting distinct methodological trade-offs. While planar cultures enable high-throughput experimentation surpassing animal model capacities, intact organisms permit multicellular analysis within complete biological networks. Although cellular platforms elucidate molecular mechanisms, their artificial microenvironments lack three-dimensional architecture and cross-tissue communication pathways. Conversely, interspecies physiological divergence in animal studies yields sub-8% therapeutic translation efficacy in oncology trials. These dual limitations underscore the imperative for engineered in vitro platforms replicating human tissue complexity to propel oncological innovation.

Prostate-on-a-chip

Microfluidic systems have become indispensable in advancing prostate cancer research through precise fluidic manipulation within micrometer-scale networks (10-1000 μm). These platforms replicate human tissue complexity by integrating heterogeneous cell populations and dynamically modulating spatiotemporal biochemical gradients, biomechanical forces, and cellular crosstalk. Engineered variants specifically model metastatic cascades—including tumor cell infiltration, vascular trafficking (intravasation/extravasation), and angiogenic induction—providing physiologically relevant insights into disease mechanisms.

Fig 2. Prostate cancer on chip.^2,4

Published Data

Scientists have pioneered a microphysiological prostate cancer platform integrating malignant epithelium with native stromal components to simulate heterocellular interactions. The architecture features vertically aligned microchannels bisected by a semipermeable interface, creating discrete neoplastic and stromal compartments. Malignant cells and fibroblasts are compartmentalized across opposing membrane surfaces, establishing dual culture environments. A 0.8 µm microporous barrier facilitates passive molecular transport through diffusion-mediated paracrine signaling, while an 8 µm macroporous variant permits cellular infiltration. The larger-pored membrane generates chemotactic gradients and enables metastatic migration through stromal invasion. Programmable perfusion systems sustain bidirectional nutrient exchange and metabolic waste clearance via independently regulated medium circulation through each microchannel.

Fig 3. Prostate-Cancer-on-Chip conceptual model.^3,4

Investigators systematically analyzed stromal cell transdifferentiation into carcinoma-associated fibroblasts (CAFs) mediated by intercellular crosstalk. Fluorescence imaging revealed malignant cells triggering CAF biomarker expression (α-smooth muscle actin, collagen I) within stromal populations. Flow-mediated spatial patterning enhanced CAF activation gradients, aligning with computational predictions of chemotactic solute distribution. Neoplastic signaling suppressed androgen receptor (AR) in stromal compartments—contrasting with AR homeostasis maintained in benign prostate microenvironments. Early metastatic invasion dynamics were probed using a microfluidic platform featuring bifurcated channels separated by nanoporous membranes. Both carcinoma cells and activated CAFs demonstrated transmigration capacity, with stromal elements actively facilitating invasive motility. Non-malignant epithelial controls exhibited neither CAF induction nor invasion potentiation. This microphysiological prostate cancer model enables time-space resolved evaluation of reciprocal tumor-stroma signaling through biomechanical and biochemical interplay, emulating in vivo tissue-scale cellular dynamics.

Applications

• Basic Cancer Research: Studying the fundamental mechanisms of prostate cancer initiation, progression, and metastasis.
• Drug Discovery and Development: Screening and evaluating the efficacy and toxicity of new anticancer drugs in a more physiologically relevant context.
• Personalized Medicine: Developing patient-specific models to predict individual responses to therapy and tailor treatment strategies.
• Tumor-Stroma Interactions: Investigating the complex interactions between prostate cancer cells and stromal cells, which play a crucial role in tumor progression and drug resistance.
• Metastasis Research: Studying the mechanisms of prostate cancer cell invasion, migration, and colonization of distant organs.
• Castration-Resistant Prostate Cancer (CRPC) Research: Developing models to study the mechanisms of CRPC and identify new therapeutic targets.

Experience the Creative Biolabs Advantage - Get a Quote Today

Why Choose Us?

Creative Biolabs is a leading provider of advanced in vitro models, with a proven track record of delivering high-quality, customized solutions for cancer research. Our Prostate-On-A-Chip Model Development Service offers several key advantages:

• Physiological Relevance: Our microfluidic models closely mimic the complex tumor microenvironment, providing more accurate and predictive results compared to traditional 2D cell cultures. As highlighted in recent research, microfluidic systems effectively promote important physiological changes in conventional prostate cancer models, enhancing their relevance to in vivo conditions.
• Customization: We tailor each Prostate-On-A-Chip model to your specific research needs, ensuring optimal performance and relevance to your study.
• Expertise: Our team comprises experienced scientists with expertise in microfluidics, cancer biology, and assay development. We provide comprehensive support throughout the project, from initial design to data analysis.
• Advanced Technology: Creative Biolabs utilizes state-of-the-art microfabrication techniques and cutting-edge technologies to create high-precision, reproducible Prostate-On-A-Chip models.
• Reproducibility and Reliability: Our models provide highly reproducible and reliable results, increasing the confidence and translatability of your research findings.
• Time and Cost Efficiency: By providing a more predictive in vitro system, our service can help accelerate your research and reduce the need for expensive and time-consuming animal studies.

FAQs

Here are some frequently asked questions about Creative Biolabs's Prostate-On-A-Chip Model Development Service:

Recommended Products

For researchers facing challenges in initiating microfluidic cellular investigations de novo, Creative Biolabs' engineered cell-culture systems deliver integrated solutions that streamline workflow bottlenecks.

Our chips offer the freedom to choose the cell seeding channels and perfusion conditions, enabling various cell culture modes.

For more information about Creative Biolabs products and services, please contact us.

References

1. Szewczyk, Kailie, et al. "Microfluidic Applications in Prostate Cancer Research." Micromachines 15.10 (2024): 1195.
2. Sassi, Amel, and Lidan You. "Microfluidics-Based Technologies for the Assessment of Castration-Resistant Prostate Cancer." Cells 13.7 (2024): 575.
3. Jiang, Linan, et al. "Microfluidic-based human prostate-cancer-on-chip." Frontiers in Bioengineering and Biotechnology 12 (2024): 1302223.
4. Distributed under Open Access license CC BY 4.0, without modification.

For Research Use Only. Not For Clinical Use.